BioMaxima S.A.
$9.54▼ 0.63%($-0.06)
TickerSpark Score
43/100
▌ Weak
72
Valuation
20
Profitability
50
Growth
44
Health
30
Momentum
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BMX.WA research report →
52-Week Range4% of range
Low
$9.30
Current
$9.54
High
$14.75
Company Overviewwww.biomaxima.com
About the company
BioMaxima S. A. produces and distributes microbiological media, reagents, and in vitro diagnostic equipment in Poland.
- CEO
- Lukasz Maria Urban
- IPO
- 2010
- Employees
- 132
- HQ
- Lublin, MZ, PL
Price Chart
-30.11% · this period
Valuation
- Market Cap
- $40.00M
- P/E
- -278.13
- P/S
- 0.67
- P/B
- 0.83
- EV/EBITDA
- 13.14
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 1.75%
- Op Margin
- -0.74%
- Net Margin
- -0.26%
- ROE
- -0.33%
- ROIC
- -0.63%
Growth & Income
- Revenue
- $60.90M · 15.24%
- Net Income
- $105.00K · -80.37%
- EPS
- $0.03 · -80.77%
- Op Income
- $-135,000
- FCF YoY
- 155.20%
Performance & Tape
- 52W High
- $14.75
- 52W Low
- $9.30
- 50D MA
- $10.85
- 200D MA
- $12.12
- Beta
- 0.29
- Avg Volume
- 4.04K
Get TickerSpark's AI analysis on BMX.WA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Coverage · BMX.WA
Our BMX.WA coverage
Recent articles, reports, and earnings notes.
On-Demand Research
No research on BMX.WA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BMX.WA report →Internal Compare
Similar companies
Peers in the same neighborhood.